Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.7250
-0.0045 (-0.62%)
At close: Jul 3, 2025, 1:00 PM
0.7289
+0.0039 (0.54%)
After-hours: Jul 3, 2025, 4:39 PM EDT

Palisade Bio Market Cap

Palisade Bio has a market cap or net worth of $3.48 million as of July 3, 2025. Its market cap has decreased by -20.98% in one year.

Market Cap
3.48M
Enterprise Value
-3.71M
1-Year Change
-20.98%
Ranking
Category
Stock Price
$0.73

Market Cap Chart

Since March 30, 2007, Palisade Bio's market cap has decreased from $82.40M to $3.48M, a decrease of -95.78%. That is a compound annual growth rate of -15.90%.

History

DateMarket Cap% Change
Jul 3, 20253.50M59.09%
Dec 31, 20242.20M-59.26%
Dec 29, 20235.40M-32.50%
Dec 30, 20228.00M-54.55%
Dec 31, 202117.60M15.79%
Dec 31, 202015.20M300.00%
Dec 31, 20193.80M-33.33%
Dec 31, 20185.70M-78.08%
Dec 29, 201726.00M-16.13%
Dec 30, 201631.00M-67.02%
Dec 31, 201594.00M-60.62%
Dec 31, 2014238.70M6.23%
Dec 31, 2013224.70M203.65%
Dec 31, 201274.00M55.14%
Dec 30, 201147.70M-51.92%
Dec 31, 201099.20M57.96%
Dec 31, 200962.80M20.54%
Dec 31, 200852.10M-54.10%
Dec 31, 2007113.50M37.74%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 699.59B
Johnson & Johnson 374.29B
AbbVie 336.94B
Novo Nordisk 309.43B
UnitedHealth Group 279.00B
Novartis AG 243.28B
Abbott Laboratories 233.33B
AstraZeneca 219.33B
Market Cap Rankings